These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 11004240
21. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability. Lindgren BF, Segovia B, Lassarre C, Binoux M, Gourmelen M. Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649 [Abstract] [Full Text] [Related]
22. Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children. Krawczuk-Rybak M, Muszyńska-Rosłan K, Kitszel A, Sawicka-Zukowska M, Wołczyński S. Rocz Akad Med Bialymst; 2005 Sep; 50():208-11. PubMed ID: 16358968 [Abstract] [Full Text] [Related]
23. Insulin-like growth factor axis, bone and collagen turnover in children with atopic dermatitis treated with topical glucocorticosteroids. Wolthers OD, Heuck C, Ternowitz T, Heickendorff L, Nielsen HK, Frystyk J. Dermatology; 1996 Sep; 192(4):337-42. PubMed ID: 8864369 [Abstract] [Full Text] [Related]
24. Relationships of serum leptin levels with biochemical markers of bone turnover and with growth factors in normal weight and overweight children. Bini V, Igli Baroncelli G, Papi F, Celi F, Saggese G, Falorni A. Horm Res; 2004 Sep; 61(4):170-5. PubMed ID: 14726619 [Abstract] [Full Text] [Related]
25. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children. Crofton PM, Stirling HF, Schönau E, Kelnar CJ. Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304 [Abstract] [Full Text] [Related]
26. Markers of type I and type III collagen turnover, insulin-like growth factors, and their binding proteins in cord plasma of small premature infants: relationships with fetal growth, gestational age, preeclampsia, and antenatal glucocorticoid treatment. Kajantie E, Hytinantti T, Koistinen R, Risteli J, Rutanen EM, Seppälä M, Andersson S. Pediatr Res; 2001 Apr; 49(4):481-9. PubMed ID: 11264430 [Abstract] [Full Text] [Related]
27. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency. Magnusson P, Degerblad M, Sääf M, Larsson L, Thorén M. J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052 [Abstract] [Full Text] [Related]
28. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis. Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF. J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819 [Abstract] [Full Text] [Related]
29. [Biochemical markers of bone formation activity in children with neoplasms]. Muszyńska-Rosłan K, Krawczuk-Rybak M, Protas P, Siedlecka E, Wiśniewska M, Wołczyński S. Wiad Lek; 2005 Sep; 58(1-2):29-35. PubMed ID: 15991550 [Abstract] [Full Text] [Related]
30. Changes of serum growth factors (IGF-I,-II and IGFBP-2,-3) prior to and after stem cell transplantation in children with acute leukemia. Dawczynski K, Kauf E, Zintl F. Bone Marrow Transplant; 2003 Aug; 32(4):411-5. PubMed ID: 12900778 [Abstract] [Full Text] [Related]
31. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy. Tobiume H, Kanzaki S, Hida S, Ono T, Moriwake T, Yamauchi S, Tanaka H, Seino Y. J Clin Endocrinol Metab; 1997 Jul; 82(7):2056-61. PubMed ID: 9215272 [Abstract] [Full Text] [Related]
32. Type 1 collagen marker of bone turnover, insulin-like growth factor, and leptin in dichorionic twins with discordant birth weight. Bajoria R, Sooranna SR, Chatterjee R. J Clin Endocrinol Metab; 2006 Nov; 91(11):4696-701. PubMed ID: 16940458 [Abstract] [Full Text] [Related]
33. Bone metabolism markers and bone mass in healthy pubertal boys and girls. van Coeverden SC, Netelenbos JC, de Ridder CM, Roos JC, Popp-Snijders C, Delemarre-van de Waal HA. Clin Endocrinol (Oxf); 2002 Jul; 57(1):107-16. PubMed ID: 12100078 [Abstract] [Full Text] [Related]
34. Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia. Mohnike KL, Kluba U, Mittler U, Aumann V, Vorwerk P, Blum WF. Eur J Pediatr; 1996 Feb; 155(2):81-6. PubMed ID: 8775218 [Abstract] [Full Text] [Related]
39. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone. Ahmed SF, Tucker P, Mushtaq T, Wallace AM, Williams DM, Hughes IA. Clin Endocrinol (Oxf); 2002 Aug; 57(2):185-91. PubMed ID: 12153596 [Abstract] [Full Text] [Related]